Parallel Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-164
Closed -$2.52K 3869
2025
Q4
$2.52K Hold
164
﹤0.01% 3072
2025
Q3
$1.63K Hold
164
﹤0.01% 3104
2025
Q2
$1.63K Sell
164
-1,892
-92% -$19.9K ﹤0.01% 3089
2025
Q1
$26.7K Sell
2,056
-61
-3% -$807 ﹤0.01% 1990
2024
Q4
$27K Buy
2,117
+1,991
+1,580% +$24.1K ﹤0.01% 1999
2024
Q3
$1.4K Buy
126
+89
+241% +$981 ﹤0.01% 2966
2024
Q2
$416 Buy
+37
New +$431 ﹤0.01% 3117
2024
Q1
Sell
-1,250
Closed -$17.5K 3329
2023
Q4
$17.5K Hold
1,250
﹤0.01% 2020
2023
Q3
$18.5K Sell
1,250
-500
-29% -$7.03K ﹤0.01% 1885
2023
Q2
$22.6K Buy
1,750
+271
+18% +$3.09K ﹤0.01% 1792
2023
Q1
$14.5K Buy
1,479
+229
+18% +$2.44K ﹤0.01% 1977
2022
Q4
$13.3K Hold
1,250
﹤0.01% 1926
2022
Q3
$13K Hold
1,250
﹤0.01% 1882
2022
Q2
$16K Hold
1,250
﹤0.01% 1759
2022
Q1
$14K Sell
1,250
-17
-1% -$206 ﹤0.01% 1862
2021
Q4
$18K Buy
1,267
+17
+1% +$280 ﹤0.01% 1836
2021
Q3
$24K Hold
1,250
﹤0.01% 1627
2021
Q2
$12K Hold
1,250
﹤0.01% 1924
2021
Q1
$12K Hold
1,250
﹤0.01% 1834
2020
Q4
$6K Sell
1,250
-300
-19% -$1.36K ﹤0.01% 1964
2020
Q3
$7K Hold
1,550
﹤0.01% 1885
2020
Q2
$13K Hold
1,550
﹤0.01% 1595
2020
Q1
$5K Hold
1,550
﹤0.01% 1888
2019
Q4
$9K Buy
1,550
+300
+24% +$1.6K ﹤0.01% 1762
2019
Q3
$4K Hold
1,250
﹤0.01% 1973
2019
Q2
$5K Hold
1,250
﹤0.01% 1810
2019
Q1
$9K Hold
1,250
﹤0.01% 1564
2018
Q4
$11K Hold
1,250
﹤0.01% 1279
2018
Q3
$16K Hold
1,250
﹤0.01% 1236
2018
Q2
$19K Hold
1,250
﹤0.01% 1071
2018
Q1
$25K Hold
1,250
﹤0.01% 920
2017
Q4
$23K Hold
1,250
﹤0.01% 965
2017
Q3
$23K Buy
+1,250
New +$19.8K ﹤0.01% 937

Other funds holding DVAX

Parallel Advisors's DVAX Position: Q1 2026 in Review

Parallel Advisors sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 164 shares — an estimated $2.52K sold.

Parallel Advisors first reported a position in DVAX in Q3 2017 and held it in 33 quarters. The position peaked at $27K in Q4 2024. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Parallel Advisors reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Parallel Advisors sold 164 Dynavax Technologies shares in Q1 2026, an estimated $2.52K.
  • Parallel Advisors first reported a position in Dynavax Technologies in Q3 2017 and held it in 33 quarters.
  • Parallel Advisors's Dynavax Technologies position peaked at $27K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.